Harry Robb

About

Leads the investment team at LifeSpan Vision Ventures, conducting analysis across the longevity biotech sector to guide investment decisions and sits on the Boards of several LifeSpan companies. Previously an investment manager at Longevity.Technology, where he built the platform's global institutional and private investor network and developed a deal pipeline valued at roughly $300 million. Interned in investment roles at FLYFWD Ventures and in business development at OXWASH. Holds an MSc in Applied Biosciences and Biotechnology from Imperial College London and a BSc in Biomedical Science from King's College London.

Source (opens in a new tab)